Back to mobile site

Citi Reiterates Buy Rating on Cabaletta Bio Inc. (CABA)

June 17, 2024 5:29 AM EDT Send to a Friend
Citi analyst Samantha Semenkow reiterated a Buy rating and $30.00 price target on Cabaletta Bio Inc. (NASDAQ: CABA)The analyst comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login